Abstract
Endometrial carcinoma is a malignant tumor of the female genital tract. This study has been performed to evaluate the chemopreventive efficacy of vanillic acid (a bio flavonoid) on endometrial carcinoma (EC) by assessing the levels of thiobarbituric acid reactive substances (TBARS), lipid hydroperoxides (LOOH), cytochrome P450, antioxidants-superoxide dismutase (SOD), catalase (CAT), glutathione peroxides (GPx), reduced glutathione (GSH), vitamins C and E, matrix metalloproteinases (MMP-2 and 9) and cell cycle check point protein (cyclin D1) in N-methyl-N′-nitro-N-nitrosoguanidine (MNNG) induced carcinogenic rats. EC provoked by intravaginal detention of MNNG (150 mg/kg b.w. for 90 days), lead to enhancement of the levels of TBARS, LOOH, cytochrome P450, and decrement in the levels of antioxidants (SOD, CAT, GPx, GSH, vitamins C and E) and upregulated expression of MMP-2 and 9 and cyclin D1 (by western blot analysis). The treatment of vanillic acid (100 mg/kg b.w.) to MNNG treated rats (1) normalized the histopathological alterations, (2) reduced the levels of TBARS, LOOH and cytochrome P450 (3) increased the levels of antioxidants (SOD, CAT, GPx, GSH, vitamins C and E) in plasma and uterus and (4) down regulated the expression of MMP-2, 9 and cyclin D1. The effect of vanillic acid is more predominant in pre-treatment group than co-treated rats. Our results designate that vanillic acid inhibits the EC by elevating antioxidants and by regulating the levels of metalloproteinase and cell cycle check point protein.
Similar content being viewed by others
References
Yasa C, Takmaz O, Dural O, Akhan SE. The value of tumor markers in endometrial carcinoma: review of literature. J Cancer Ther. 2013;4:966–70.
Janiec-Jankowska A, Konopka B, Goluda C, Najmoła U. Tp53 mutations in endometrial cancers: relation to PTEN gene defects. Int J Gynecol Cancer. 2010;20:196–202.
Edara S, Kanugula S, Pegg AE. Expression of the inactive C145A mutant human O6-alkylguanine-DNA alkyltransferase in E. coli increases cell killing and mutations by N-methyl-N′-nitro-N-nitrosoguanidine. Carcinogenesis. 1999;20:103–8.
Cerutti PA. Oxy-radicals and cancer. Lancet. 1994;344:862–3.
Subapriya R, Kumaraguruparan R, Chandramohan KVP, Nagini S. Chemopreventive effects of ethanolic neem leaf extract against MNNG-induced oxidative stress. Pharmazie. 2003;58:512–7.
Puljiz M, Puljiz Z, Vucemilo T, Ramić S, Knezević F, Culo B, et al. Prognostic significance of matrix metalloproteinases 2 and 9 in endometrial cancer. Coll Antropol. 2012;4:1367–72.
Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL. Cyclin D1 as a therapeutic target in cancer. Nat Rev Cancer. 2011;11:558–72.
Ghasemzadeh A, Omidvar V, Jaafar HZE. Polyphenolic content and their antioxidant activity in leaf extract of sweet potato (Ipomoea batatas). J Med Plants Res. 2012;6:2971–6.
Dhananjaya BL, Nataraju A, Raghavendra Gowda CD, Sharath BK, D’Souza CJ. Vanillic acid as a novel specific inhibitor of snake venom 5′-nucleotidase: a pharmacological tool in evaluating the role of the enzyme in snake envenomation. Biochemistry. 2009;74:1315–9.
Vetrano AM, Heck DE, Mariano TM, Mishin V, Laskin DL, Laskin JD. Characterization of the oxidase activity in mammalian catalase. J Biol Chem. 2005;280:35372–81.
Itoh A, Isoda K, Kondoh M, Kawase M, Kobayashi M, Tamesada M, et al. Hepatoprotective effect of syringic acid and vanillic acid on concanavalin a induced liver injury. Biol Pharm Bull. 2009;32:1215–9.
Yagi K. Lipid peroxides and human disease. Chem Phys Lipids. 1987;45:337–51.
Jiang ZY, Hunt JV, Wolff SP. Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxides in low density lipoprotein. Anal Biochem. 1992;202:384–9.
Omura T, Sato R. The carbon monoxide binding pigment of liver. J Biol Chem. 1964;239:2370–8.
Kakkar PS, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Ind J Biochem Biophys. 1984;21:130–2.
Sinha KA. Colorimetric assay of catalase. Anal Biochem. 1972;47:389–94.
Ellman GL. Tissue sulphydryl groups. Arch Biochem Biophys. 1959;82:72–7.
Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science. 1973;179:588–90.
Roe JM, Kuether CA. Detection of ascorbic acid in whole blood, and urine through 2,4-DNPH derivative of dehydroascorbic acid. J Biol Chem. 1943;147:399–407.
Baker H, Frank O, De Angelis B, Feingold S. Plasma tocopherol in man at various times after ingesting free or acetylated tocopherol. Nutr Rep Int. 1980;21:531–6.
Kodama Y, Ozaki K, Sano T, Matsuura T, Narama I. Enhanced tumorigenesis of forestomach tumors induced by N-methyl-N′-nitro-N-nitrosoguanidine in rats with hypoinsulinemic diabetes. Cancer Sci. 2010;101:1604–9.
Alizadeh AM, Afrouzan H, Dinparast-Djadid N, Sawaya AC, Azizian S, Hemmati HR, et al. Chemoprotection of MNNG-initiated gastric cancer in rats using Iranian Propolis. Arch Iran Med. 2015;18:18–23.
Bandebuche S, Melinkeri RR. Oxidative stress and antioxidant status in patients of ovarian cancer. Biomed Res. 2011;22:196–200.
Sathiyapriya J, Rajeswari K, Annamalai G, Sivakumar K, Suresh K. Chemopreventive and antioxidant efficacy of fisetin in experimental oral carcinogenesis. Int J Rec Sci Res. 2013;4:313–9.
Ravid A, Rocker D, Machlenkin A, Rotem C, Hochman A, Essler- Icekson G, et al. 1, 25-Dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin induced oxidative damage. Cancer Res. 1999;59:862–7.
Liu N, Huang J, Sun S, Zhou Z, Zhang J, Gao F, et al. Expression of matrix metalloproteinase-9, cyclooxygenase-2 and vascular endothelial growth factor are increased in gastrointestinal stromal tumors. Int J Clin Exp Med. 2015;8:6495–501.
Gialeli C, Theocharis AD, Karamanos NK. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J. 2010;278:16–27.
Small AR, Neagu A, Amyot F, Sackett D, Chernomordik V, Gandjbakhche A. Spatial distribution of VEGF isoforms and chemotactic signals in the vicinity of a tumour. J Theor Biol. 2008;252:593–607.
Kim JK, Diel JA. Nuclear cyclin D1: an oncogenic driver in human cancer. J Cell Physiol. 2009;2020:292–6.
Choi YJ, Li X, Hydbring P. The requirement for cyclin D function in tumor maintenance. Cancer Cell. 2012;22:438–51.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest.
Rights and permissions
About this article
Cite this article
Bhavani, P., Subramanian, P. & Kanimozhi, S. Preventive Efficacy of Vanillic Acid on Regulation of Redox Homeostasis, Matrix Metalloproteinases and Cyclin D1 in Rats Bearing Endometrial Carcinoma. Ind J Clin Biochem 32, 429–436 (2017). https://doi.org/10.1007/s12291-016-0605-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-016-0605-6